Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

A Novel Hypoxia-Inducible Factor−Prolyl Hydroxylase Inhibitor (GSK1278863) for Anemia in CKD: A 28-Day, Phase 2A Randomized Trial

PaperCitations, authors & open-access status

A Novel Hypoxia-Inducible Factor−Prolyl Hydroxylase Inhibitor (GSK1278863) for Anemia in CKD: A 28-Day, Phase 2A Randomized Trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 164 citations, 2016 year and hybrid oa status.

164
Citations
2016
Year
hybrid
OA Status

Related on ScholarIQ

Manisha Sahay
Author
Elena Zakharova
Author
American Journal of Kidney Diseases
Journal
Erythropoietin and Anemia Treatment
Topic
Erythropoietin and Anemia Treatment
Topic
Cancer, Hypoxia, and Metabolism
Topic
470M+ articles · free account